List of Excipients in API DEXTROAMPHETAMINE SULFATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing DEXTROAMPHETAMINE SULFATE
Excipients in ANDA-approved (generic) drugs containing DEXTROAMPHETAMINE SULFATE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8958 | CELLULOSE, MICROCRYSTALLINE |
| SpecGx LLC | dextroamphetamine sulfate | 0406-8958 | POVIDONE |
| SpecGx LLC | dextroamphetamine sulfate | 0406-8958 | SILICON DIOXIDE |
| SpecGx LLC | dextroamphetamine sulfate | 0406-8958 | STEARIC ACID |
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 | ALCOHOL |
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 | ALUMINUM OXIDE |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for DEXTROAMPHETAMINE SULFATE
Excipient focus: ALCOHOL
DEXTROAMPHETAMINE SULFATE drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| Mayne Pharma Inc | dextroamphetamine sulfate | 51862-344 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
DEXTROAMPHETAMINE SULFATE drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| Physicians Total Care Inc | dextroamphetamine sulfate | 54868-5479 |
| Ethex Corporation | dextroamphetamine sulfate | 58177-311 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
DEXTROAMPHETAMINE SULFATE drug variants containing AMMONIA
DEXTROAMPHETAMINE SULFATE drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
DEXTROAMPHETAMINE SULFATE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BENZOIC ACID
DEXTROAMPHETAMINE SULFATE drug variants containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing BENZOIC ACID
Excipient focus: BUTYL ALCOHOL
DEXTROAMPHETAMINE SULFATE drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| Mayne Pharma Inc | dextroamphetamine sulfate | 51862-344 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing BUTYL ALCOHOL
Excipient focus: CALCIUM PHOSPHATE
DEXTROAMPHETAMINE SULFATE drug variants containing CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | dextroamphetamine sulfate | 27808-089 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing CALCIUM PHOSPHATE
Excipient focus: CALCIUM SULFATE
DEXTROAMPHETAMINE SULFATE drug variants containing CALCIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | dextroamphetamine sulfate | 0555-0952 |
| Zydus Pharmaceuticals (USA) Inc | dextroamphetamine sulfate | 68382-941 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing CALCIUM SULFATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
DEXTROAMPHETAMINE SULFATE drug variants containing CELLULOSE, MICROCRYSTALLINE
DEXTROAMPHETAMINE SULFATE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CETYL ALCOHOL
DEXTROAMPHETAMINE SULFATE drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | dextroamphetamine sulfate | 0115-1702 |
| Amneal Pharmaceuticals of New York LLC | dextroamphetamine sulfate | 0115-9927 |
| Amneal Pharmaceuticals LLC | dextroamphetamine sulfate | 64896-673 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing CETYL ALCOHOL
Excipient focus: CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
DEXTROAMPHETAMINE SULFATE drug variants containing CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
Excipient focus: CROSPOVIDONE
DEXTROAMPHETAMINE SULFATE drug variants containing CROSPOVIDONE
DEXTROAMPHETAMINE SULFATE drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 27
DEXTROAMPHETAMINE SULFATE drug variants containing D&C RED NO. 27
| Company | Ingredient | NDC |
|---|---|---|
| Wilshire Pharmaceuticals Inc | dextroamphetamine sulfate | 52536-500 |
| Bryant Ranch Prepack | dextroamphetamine sulfate | 72162-2349 |
| Bryant Ranch Prepack | dextroamphetamine sulfate | 72162-2352 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing D&C RED NO. 27
Excipient focus: D&C RED NO. 28
DEXTROAMPHETAMINE SULFATE drug variants containing D&C RED NO. 28
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | dextroamphetamine sulfate | 64380-230 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing D&C RED NO. 28
Excipient focus: D&C YELLOW NO. 10
DEXTROAMPHETAMINE SULFATE drug variants containing D&C YELLOW NO. 10
DEXTROAMPHETAMINE SULFATE drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
DEXTROAMPHETAMINE SULFATE drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
DEXTROAMPHETAMINE SULFATE drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: DIBUTYL SEBACATE
DEXTROAMPHETAMINE SULFATE drug variants containing DIBUTYL SEBACATE
DEXTROAMPHETAMINE SULFATE drug variants not containing DIBUTYL SEBACATE
Excipient focus: ETHYLCELLULOSE
DEXTROAMPHETAMINE SULFATE drug variants containing ETHYLCELLULOSE
DEXTROAMPHETAMINE SULFATE drug variants not containing ETHYLCELLULOSE
Excipient focus: ETHYLCELLULOSES
DEXTROAMPHETAMINE SULFATE drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma Inc | dextroamphetamine sulfate | 51862-344 |
| Physicians Total Care Inc | dextroamphetamine sulfate | 54868-5479 |
| Amneal Pharmaceuticals LLC | dextroamphetamine sulfate | 64896-673 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing ETHYLCELLULOSES
Excipient focus: FD&C BLUE NO. 1
DEXTROAMPHETAMINE SULFATE drug variants containing FD&C BLUE NO. 1
DEXTROAMPHETAMINE SULFATE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
DEXTROAMPHETAMINE SULFATE drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
DEXTROAMPHETAMINE SULFATE drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
DEXTROAMPHETAMINE SULFATE drug variants containing FD&C BLUE NO. 2
DEXTROAMPHETAMINE SULFATE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
DEXTROAMPHETAMINE SULFATE drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
DEXTROAMPHETAMINE SULFATE drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C RED NO. 40
DEXTROAMPHETAMINE SULFATE drug variants containing FD&C RED NO. 40
DEXTROAMPHETAMINE SULFATE drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
DEXTROAMPHETAMINE SULFATE drug variants containing FD&C YELLOW NO. 6
DEXTROAMPHETAMINE SULFATE drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
DEXTROAMPHETAMINE SULFATE drug variants containing FERRIC OXIDE RED
DEXTROAMPHETAMINE SULFATE drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
DEXTROAMPHETAMINE SULFATE drug variants containing FERRIC OXIDE YELLOW
DEXTROAMPHETAMINE SULFATE drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
DEXTROAMPHETAMINE SULFATE drug variants containing FERROSOFERRIC OXIDE
DEXTROAMPHETAMINE SULFATE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
DEXTROAMPHETAMINE SULFATE drug variants containing GELATIN
DEXTROAMPHETAMINE SULFATE drug variants not containing GELATIN
Excipient focus: HYDROXYPROPYL CELLULOSE
DEXTROAMPHETAMINE SULFATE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| Mayne Pharma Inc | dextroamphetamine sulfate | 51862-344 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
DEXTROAMPHETAMINE SULFATE drug variants containing HYPROMELLOSE
DEXTROAMPHETAMINE SULFATE drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
DEXTROAMPHETAMINE SULFATE drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
DEXTROAMPHETAMINE SULFATE drug variants containing HYPROMELLOSE 2910
DEXTROAMPHETAMINE SULFATE drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
DEXTROAMPHETAMINE SULFATE drug variants containing HYPROMELLOSES
DEXTROAMPHETAMINE SULFATE drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
DEXTROAMPHETAMINE SULFATE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| Mayne Pharma Inc | dextroamphetamine sulfate | 51862-344 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
DEXTROAMPHETAMINE SULFATE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Novel Laboratories Inc | dextroamphetamine sulfate | 40032-870 |
| Lupin PharmaceuticalsInc | dextroamphetamine sulfate | 43386-870 |
| Strides Pharma Science Limited | dextroamphetamine sulfate | 64380-218 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
DEXTROAMPHETAMINE SULFATE drug variants containing MAGNESIUM STEARATE
DEXTROAMPHETAMINE SULFATE drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
DEXTROAMPHETAMINE SULFATE drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | dextroamphetamine sulfate | 0555-0952 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing MALTODEXTRIN
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
DEXTROAMPHETAMINE SULFATE drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| Mayne Pharma Inc | dextroamphetamine sulfate | 51862-344 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
DEXTROAMPHETAMINE SULFATE drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
DEXTROAMPHETAMINE SULFATE drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
DEXTROAMPHETAMINE SULFATE drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
DEXTROAMPHETAMINE SULFATE drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: METHYLCELLULOSE
DEXTROAMPHETAMINE SULFATE drug variants containing METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | dextroamphetamine sulfate | 54868-5479 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing METHYLCELLULOSE
Excipient focus: OLEIC ACID
DEXTROAMPHETAMINE SULFATE drug variants containing OLEIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| Mayne Pharma Inc | dextroamphetamine sulfate | 51862-344 |
| Zydus Pharmaceuticals (USA) Inc | dextroamphetamine sulfate | 68382-943 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing OLEIC ACID
Excipient focus: POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW)
DEXTROAMPHETAMINE SULFATE drug variants containing POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW)
| Company | Ingredient | NDC |
|---|---|---|
| Takeda Pharmaceuticals America Inc | dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine aspartate monohydrate, and amphetamine sulfate | 54092-468 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW)
Excipient focus: POLYETHYLENE GLYCOL
DEXTROAMPHETAMINE SULFATE drug variants containing POLYETHYLENE GLYCOL
DEXTROAMPHETAMINE SULFATE drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
DEXTROAMPHETAMINE SULFATE drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | dextroamphetamine sulfate | 64380-230 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
DEXTROAMPHETAMINE SULFATE drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
DEXTROAMPHETAMINE SULFATE drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POTASSIUM HYDROXIDE
DEXTROAMPHETAMINE SULFATE drug variants containing POTASSIUM HYDROXIDE
DEXTROAMPHETAMINE SULFATE drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
DEXTROAMPHETAMINE SULFATE drug variants containing POVIDONE
DEXTROAMPHETAMINE SULFATE drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
DEXTROAMPHETAMINE SULFATE drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | dextroamphetamine sulfate | 68382-943 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
DEXTROAMPHETAMINE SULFATE drug variants containing PROPYLENE GLYCOL
DEXTROAMPHETAMINE SULFATE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SACCHARIN SODIUM
DEXTROAMPHETAMINE SULFATE drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing SACCHARIN SODIUM
Excipient focus: SHELLAC
DEXTROAMPHETAMINE SULFATE drug variants containing SHELLAC
DEXTROAMPHETAMINE SULFATE drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
DEXTROAMPHETAMINE SULFATE drug variants containing SILICON DIOXIDE
DEXTROAMPHETAMINE SULFATE drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
DEXTROAMPHETAMINE SULFATE drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
DEXTROAMPHETAMINE SULFATE drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | dextroamphetamine sulfate | 64380-230 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
DEXTROAMPHETAMINE SULFATE drug variants containing SODIUM LAURYL SULFATE
DEXTROAMPHETAMINE SULFATE drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
DEXTROAMPHETAMINE SULFATE drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | dextroamphetamine sulfate | 27808-089 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBITOL
DEXTROAMPHETAMINE SULFATE drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| >Company | >Ingredient | >NDC |
DEXTROAMPHETAMINE SULFATE drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
DEXTROAMPHETAMINE SULFATE drug variants containing STARCH, CORN
DEXTROAMPHETAMINE SULFATE drug variants not containing STARCH, CORN
Excipient focus: STEARIC ACID
DEXTROAMPHETAMINE SULFATE drug variants containing STEARIC ACID
DEXTROAMPHETAMINE SULFATE drug variants not containing STEARIC ACID
Excipient focus: SUCROSE
DEXTROAMPHETAMINE SULFATE drug variants containing SUCROSE
DEXTROAMPHETAMINE SULFATE drug variants not containing SUCROSE
Excipient focus: TALC
DEXTROAMPHETAMINE SULFATE drug variants containing TALC
DEXTROAMPHETAMINE SULFATE drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
DEXTROAMPHETAMINE SULFATE drug variants containing TITANIUM DIOXIDE
DEXTROAMPHETAMINE SULFATE drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIETHYL CITRATE
DEXTROAMPHETAMINE SULFATE drug variants containing TRIETHYL CITRATE
DEXTROAMPHETAMINE SULFATE drug variants not containing TRIETHYL CITRATE
Excipient focus: WATER
DEXTROAMPHETAMINE SULFATE drug variants containing WATER
DEXTROAMPHETAMINE SULFATE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
